Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Mar 2022 for Brainstorm Cell Therapeutics INC.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Ralph Dr. Kern: trading record in brief
Ralph Dr. Kern (chief executive) discloses dealings in Brainstorm Cell Therapeutics Inc. to SEC (Form 4). Over a trading history stretching from 10 December 2021 to 6 March 2022, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 14 March 2022 came the latest disclosure, a share grant in Brainstorm Cell Therapeutics Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ralph Dr. Kern
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
35,885 shares0Common StockSEC:0001104659-22-033496:0
35,885 shares0Common StockSEC:0001104659-21-148754:0
2 of 2 declarations
